RxDoctor Payments Data
★ My doctorsLook up a doctor →

Salma Aziz, DPM

Podiatry · Rancho Santa Margarita, CANPI 1467447326

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 98.4% of the total across 250 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 25 manufacturers, the largest accounting for just 20.8% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,374, 2.2 times the $635 reported in 2019. Among podiatry clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$6,352in general payments, 2019–2025

Across 250 payments — averaging $25.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$1K
  • Surgenex LLC$1K
  • Biotissue Holdings Inc.$928
  • Integra Lifesciences Corporation$569
  • Smith+Nephew$417
  • Amgen$325
  • plus $2K from 19 others

What the payments were for

  • Food & beverage$6,25198%
  • Education$1012%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Stryker42$1,324
Surgenex LLC28$1,127
Biotissue Holdings Inc.29$928
Integra Lifesciences Corporation27$569
Smith+Nephew19$417
Amgen25$325
Bioventus LLC8$203
Zimmer Biomet5$200
Paragon 28, Inc.2$200
Sandoz15$191
Sebela Pharmaceuticals Inc.17$186
Ortho Dermatologics, A Division Of Bausch Health US, LLC9$143
Averitas Pharma Inc.3$111
Pfizer4$96
Nevro Corp.2$56
Linvatec Corporation2$41
Nabriva Therapeutics, PLC2$39
Galderma Laboratories, L.p.2$39
ANI Pharmaceuticals, Inc.2$34
Misonix Inc2$34
Acell, Inc.1$24
Assertio Therapeutics, Inc.1$19
Incyte Corporation1$18
Paratek Pharmaceuticals, Inc.1$16
Mayne Pharma Commercial LLC1$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,352 in reported general payments places this provider in the 95th percentile of 136 podiatry providers in California.

See all podiatry providers in California →

Medicare billing

Part B allowed, 2024
$92,751
Medicare patients
197
Services billed
1,199

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Cephalexin17$72

Paid to pharmacies, not to this prescriber.

Other podiatry in Rancho Santa Margarita

See the full list for California →

Where these figures come from

Is this you, or does something look wrong? →